What is the address of Dr. Jan Dobbelaere, Neurologie?

The registered office of Dr. Jan Dobbelaere, Neurologie is located at Kloosterweg 6, 3020 Herent.

Is Dr. Jan Dobbelaere, Neurologie still active?

Yes. According to the CBE (28 September 2026) Dr. Jan Dobbelaere, Neurologie is active, legal situation “Normale toestand”, started on 24 January 2017.

Is Dr. Jan Dobbelaere, Neurologie registered on Peppol?

No, Dr. Jan Dobbelaere, Neurologie is currently not registered on the Peppol network.

What is the enterprise number of Dr. Jan Dobbelaere, Neurologie?

The enterprise number of Dr. Jan Dobbelaere, Neurologie is BE0669894668.

When was Dr. Jan Dobbelaere, Neurologie founded?

Dr. Jan Dobbelaere, Neurologie was founded on 24 January 2017.

Who are the directors of Dr. Jan Dobbelaere, Neurologie?

According to the 2025 annual accounts, the directors of Dr. Jan Dobbelaere, Neurologie are: JAN DOBBELAERE.

Is Dr. Jan Dobbelaere, Neurologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 January 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Jan Dobbelaere, Neurologie make in 2025?

Dr. Jan Dobbelaere, Neurologie posted a profit after taxes of € 146,970 in financial year 2025.

What is the revenue of Dr. Jan Dobbelaere, Neurologie?

As a small company, Dr. Jan Dobbelaere, Neurologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 161,100.

How many employees does Dr. Jan Dobbelaere, Neurologie have?

According to the 2025 annual accounts, Dr. Jan Dobbelaere, Neurologie has 0 full-time equivalents (FTE).

Dr. Jan Dobbelaere, Neurologie (Private Limited) - Herent

Dossier Dr. Jan Dobbelaere, Neurologie, printed on 28 September 2026 from databakkes.be/en/0669894668/dr-jan-dobbelaere-neurologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Jan Dobbelaere, Neurologie from Herent, company number BE0669894668, closed financial year 2025 with a result of € 146,970 after tax. For that financial year Dr. Jan Dobbelaere, Neurologie recorded a gross margin of € 161,100 and equity of € 684,438. Compared with financial year 2024, the result moved from € 97,673 to € 146,970. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Growing

€ 684,438

▲ 27% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 146,970

▲ 50% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 68,454

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 672,038.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 38,225

▲ € 36,755 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,311

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 34,789

▲ 98% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 113,284 Gross margin 2022: € 113,284 First fiscal year in the series	€ 122,496 Gross margin 2023: € 122,496 ▲ 8% vs 2022 (€ 113,284) Favourable step	€ 132,596 Gross margin 2024: € 132,596 ▲ 8% vs 2023 (€ 122,496) Favourable step	€ 161,100 Gross margin 2025: € 161,100 ▲ 21% vs 2024 (€ 132,596) Favourable step	▲ 21%
Profit after taxes	€ 76,096 Profit after taxes 2022: € 76,096 First fiscal year in the series	€ 86,669 Profit after taxes 2023: € 86,669 ▲ 14% vs 2022 (€ 76,096) Favourable step	€ 97,673 Profit after taxes 2024: € 97,673 ▲ 13% vs 2023 (€ 86,669) Favourable step	€ 146,970 Profit after taxes 2025: € 146,970 ▲ 50% vs 2024 (€ 97,673) Favourable step	▲ 50%
Equity	€ 353,126 Equity 2022: € 353,126 First fiscal year in the series	€ 439,795 Equity 2023: € 439,795 ▲ 25% vs 2022 (€ 353,126) Favourable step	€ 537,468 Equity 2024: € 537,468 ▲ 22% vs 2023 (€ 439,795) Favourable step	€ 684,438 Equity 2025: € 684,438 ▲ 27% vs 2024 (€ 537,468) Favourable step	▲ 27%
Total debts	€ 21,705 Total debts 2022: € 21,705 First fiscal year in the series	€ 26,812 Total debts 2023: € 26,812 ▲ 24% vs 2022 (€ 21,705) Unfavourable step	€ 24,027 Total debts 2024: € 24,027 ▼ 10% vs 2023 (€ 26,812) Favourable step	€ 41,235 Total debts 2025: € 41,235 ▲ 72% vs 2024 (€ 24,027) Unfavourable step	▲ 72%
Cash	€ 195,727 Cash 2022: € 195,727 First fiscal year in the series	€ 244,959 Cash 2023: € 244,959 ▲ 25% vs 2022 (€ 195,727) Favourable step	€ 93,668 Cash 2024: € 93,668 ▼ 62% vs 2023 (€ 244,959) Unfavourable step	€ 68,454 Cash 2025: € 68,454 ▼ 27% vs 2024 (€ 93,668) Unfavourable step	▼ 27%
Retained profit	€ 340,726 Retained profit 2022: € 340,726 First fiscal year in the series	€ 427,395 Retained profit 2023: € 427,395 ▲ 25% vs 2022 (€ 340,726) Favourable step	€ 525,068 Retained profit 2024: € 525,068 ▲ 23% vs 2023 (€ 427,395) Favourable step	€ 672,038 Retained profit 2025: € 672,038 ▲ 28% vs 2024 (€ 525,068) Favourable step	▲ 28%
Balance sheet total	€ 374,831 Balance sheet total 2022: € 374,831 First fiscal year in the series	€ 466,606 Balance sheet total 2023: € 466,606 ▲ 24% vs 2022 (€ 374,831) Unchanged	€ 561,494 Balance sheet total 2024: € 561,494 ▲ 20% vs 2023 (€ 466,606) Unchanged	€ 725,673 Balance sheet total 2025: € 725,673 ▲ 29% vs 2024 (€ 561,494) Unchanged	▲ 29%

Key figures of Dr. Jan Dobbelaere, Neurologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Jan Dobbelaere, Neurologie?

What happened at Dr. Jan Dobbelaere, Neurologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: profit of € 146,970 (▲ 50% vs 2024). Source: NBB ↗
Jan 24, 2017 New establishment in Herent. KBO
Jan 24, 2017 Start of the company according to the CBE. KBO

In short

From € 76,096 profit in 2022 to € 146,970 profit in 2025.

Paid € 163,179 in corporate taxes since 2022.

Best year ever: 2025, with € 146,970 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Jan Dobbelaere, Neurologie? We notify you, reason included.

Follow Dr. Jan Dobbelaere, Neurologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

JAN DOBBELAERE

Dr. Jan Dobbelaere, Neurologie

Behind Dr. Jan Dobbelaere, Neurologie is JAN DOBBELAERE.

See the full network in the app

Directors

According to the 2025 annual accounts

JAN DOBBELAERE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kloosterweg 6

3020 Herent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0669.894.668
VAT number: BE 0669.894.668
Registered office: Kloosterweg 6, 3020 Herent
Names & denominations: Dr. Jan Dobbelaere, Neurologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 January 2017
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗